FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378234863> ?p ?o ?g. }

• W4378234863 abstract "In this study, two new series of 3-cyanopyridinones (3a–e) and 3-cyanopyridines (4a–e) were synthesized and evaluated for their cytotoxicity and Pim-1 kinase inhibitory activity adopting 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay and in vitro Pim-1 kinase inhibition assay, respectively. Most of the tested compounds revealed promising cytotoxicity against HepG-2, HCT-116, MCF-7, and PC-3 cell lines. Among them, compounds 4c and 4d showed more potent cytotoxicity against the HePG2 cell line with IC50 = 8.02 ± 0.38 and 6.95 ± 0.34 μM, respectively, than that of the reference 5-FU (IC50 = 9.42 ± 0.46 μM). Moreover, compound 4c was more potent against HCT-116 (IC50 = 7.15 ± 0.35 μM) than 5-FU (IC50 = 8.01 ± 0.39 μM), while compound 4d with IC50 = 8.35 ± 0.42 μM displayed comparable activity to that of the reference drug. Furthermore, high cytotoxic activity was manifested by compounds 4c and 4d against MCF-7 and PC3 cell lines. Our results have also indicated that compounds 4b, 4c, and 4d elicited remarkable inhibition of Pim-1 kinase; 4b and 4c showed equipotent inhibitory activity to that of the reference quercetagetin. Meanwhile, 4d displayed IC50 = 0.46 ± 0.02 μM, showed the best inhibitory activity among the tested compounds, and was more potent than quercetagetin (IC50 = 0.56 ± 0.03 μM). For optimization of the results, docking study of the most potent compounds 4c and 4d in the Pim-1 kinase active site was carried out and compared with both quercetagetin and the reported Pim-1 inhibitor A (VRV), and the results were consistent with those of the biological study. Consequently, compounds 4c and 4d are worthy of further investigations toward the discovery of Pim-1 kinase inhibitors as drug candidates for cancer therapy. Compound 4b was successfully radiolabeled with radioiodine-131, and its biodistribution in Ehrlich ascites carcinoma (EAC)-bearing mice showed more observable uptake in tumor sites, and hence, it can be introduced as a new radiolabeled agent for tumor imaging and therapy." @default.
• W4378234863 created "2023-05-26" @default.
• W4378234863 creator A5000487211 @default.
• W4378234863 creator A5005212824 @default.
• W4378234863 creator A5010699938 @default.
• W4378234863 creator A5033384433 @default.
• W4378234863 creator A5035496320 @default.
• W4378234863 creator A5081294319 @default.
• W4378234863 date "2023-05-24" @default.
• W4378234863 modified "2023-09-27" @default.
• W4378234863 title "Cyanopyridinone- and Cyanopyridine-Based Cancer Cell Pim-1 Inhibitors: Design, Synthesis, Radiolabeling, Biodistribution, and Molecular Modeling Simulation" @default.
• W4378234863 cites W1604058700 @default.
• W4378234863 cites W1629179716 @default.
• W4378234863 cites W1857478378 @default.
• W4378234863 cites W1991667474 @default.
• W4378234863 cites W2000470970 @default.
• W4378234863 cites W2007083616 @default.
• W4378234863 cites W2012953173 @default.
• W4378234863 cites W2039409268 @default.
• W4378234863 cites W2048008261 @default.
• W4378234863 cites W2050066735 @default.
• W4378234863 cites W2052258185 @default.
• W4378234863 cites W2072759537 @default.
• W4378234863 cites W2094761664 @default.
• W4378234863 cites W2099825600 @default.
• W4378234863 cites W2114918609 @default.
• W4378234863 cites W2126595940 @default.
• W4378234863 cites W2145446216 @default.
• W4378234863 cites W2166616170 @default.
• W4378234863 cites W2277143088 @default.
• W4378234863 cites W2296264213 @default.
• W4378234863 cites W2515382091 @default.
• W4378234863 cites W2557911206 @default.
• W4378234863 cites W2606502087 @default.
• W4378234863 cites W2735767394 @default.
• W4378234863 cites W2790518568 @default.
• W4378234863 cites W2791150863 @default.
• W4378234863 cites W2801398807 @default.
• W4378234863 cites W2805555742 @default.
• W4378234863 cites W2887217759 @default.
• W4378234863 cites W2913043947 @default.
• W4378234863 cites W2914861485 @default.
• W4378234863 cites W2979627812 @default.
• W4378234863 cites W3005826874 @default.
• W4378234863 cites W3021909056 @default.
• W4378234863 cites W3036149288 @default.
• W4378234863 cites W3036985815 @default.
• W4378234863 cites W3093134926 @default.
• W4378234863 cites W3095300863 @default.
• W4378234863 cites W3120791704 @default.
• W4378234863 cites W3135979641 @default.
• W4378234863 cites W3184529034 @default.
• W4378234863 cites W4200206751 @default.
• W4378234863 cites W4220949100 @default.
• W4378234863 cites W4225395671 @default.
• W4378234863 cites W4251335296 @default.
• W4378234863 cites W4295956607 @default.
• W4378234863 cites W4321486996 @default.
• W4378234863 doi "https://doi.org/10.1021/acsomega.2c08304" @default.
• W4378234863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37305261" @default.
• W4378234863 hasPublicationYear "2023" @default.
• W4378234863 type Work @default.
• W4378234863 citedByCount "0" @default.
• W4378234863 crossrefType "journal-article" @default.
• W4378234863 hasAuthorship W4378234863A5000487211 @default.
• W4378234863 hasAuthorship W4378234863A5005212824 @default.
• W4378234863 hasAuthorship W4378234863A5010699938 @default.
• W4378234863 hasAuthorship W4378234863A5033384433 @default.
• W4378234863 hasAuthorship W4378234863A5035496320 @default.
• W4378234863 hasAuthorship W4378234863A5081294319 @default.
• W4378234863 hasBestOaLocation W43782348631 @default.
• W4378234863 hasConcept C109316439 @default.
• W4378234863 hasConcept C159110408 @default.
• W4378234863 hasConcept C178790620 @default.
• W4378234863 hasConcept C184235292 @default.
• W4378234863 hasConcept C185592680 @default.
• W4378234863 hasConcept C202751555 @default.
• W4378234863 hasConcept C2776300020 @default.
• W4378234863 hasConcept C2777752112 @default.
• W4378234863 hasConcept C2777752497 @default.
• W4378234863 hasConcept C2777807558 @default.
• W4378234863 hasConcept C2780783641 @default.
• W4378234863 hasConcept C41685203 @default.
• W4378234863 hasConcept C54355233 @default.
• W4378234863 hasConcept C55493867 @default.
• W4378234863 hasConcept C71240020 @default.
• W4378234863 hasConcept C71924100 @default.
• W4378234863 hasConcept C81885089 @default.
• W4378234863 hasConcept C86803240 @default.
• W4378234863 hasConcept C98274493 @default.
• W4378234863 hasConceptScore W4378234863C109316439 @default.
• W4378234863 hasConceptScore W4378234863C159110408 @default.
• W4378234863 hasConceptScore W4378234863C178790620 @default.
• W4378234863 hasConceptScore W4378234863C184235292 @default.
• W4378234863 hasConceptScore W4378234863C185592680 @default.
• W4378234863 hasConceptScore W4378234863C202751555 @default.
• W4378234863 hasConceptScore W4378234863C2776300020 @default.
• W4378234863 hasConceptScore W4378234863C2777752112 @default.
• W4378234863 hasConceptScore W4378234863C2777752497 @default.
• W4378234863 hasConceptScore W4378234863C2777807558 @default.

• next